Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2025-12-24 @ 5:55 PM
NCT ID:
NCT00348868
Eligibility Criteria:
Inclusion Criteria:
* HIV infection
* Receiving or seeking outpatient HIV care
* Seeking outpatient treatment for opioid dependence and be willing to take buprenorphine
* Meets DSM-IV criteria for opioid dependence, and be willing to stop illicit opioid use and be experiencing early symptoms of opioid withdrawal at the time that buprenorphine is given
* Men and women age ≥ 18 years
* Women of reproductive potential must have a negative serum or urine pregnancy test result available within 7 days prior to initiating buprenorphine
* Within 30 days: (SGOT), ALT (SGPT), and alkaline phosphatase \<=5 X ULN, Total bilirubin \<= 2.5 x ULN
Exclusion Criteria:
* Serious medical problem
* Acute and/or severe psychiatric conditions
* High dose methadone (\>30 mg/day)
* Documented co-dependence on alcohol and/or benzodiazepines, barbiturates
* Chronic pain management requiring opioids
* Pregnancy or breast-feeding
* Imprisonment or involuntary incarceration in a medical facility for psychiatric or physical
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00348868
Study Brief:
Protocol Section:
NCT00348868